Thursday, July 9, 2026

HLB’s Liraglutide: A Game-Changer in Cholangiocarcinoma Treatment with FDA Priority Review

HLB's Elevar Therapeutics receives FDA Priority Review for lirafugratinib, a promising treatment for cholangiocarcinoma with a 47% response rate.

Will the Jones Act Change? Insights from South Korea’s Song Young-gil on U.S.-Korea Shipbuilding Cooperation

Song Young-gil emphasizes the need for U.S. cooperation in shipbuilding and warns of challenges without Jones Act amendments.

Washington Rolls Back Climate Finding, but Cost Relief for Korean Carmakers May Be Limited

The U.S. ends greenhouse gas regulations, impacting South Korea's auto and battery sectors, with mixed effects on costs and EV transition.

Tag: urothelial carcinoma

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

CT-P71: The New ADC Cancer Drug Fast-Tracked by FDA for Urothelial Carcinoma

Celltrion's CT-P71 receives FDA Fast Track designation for urothelial carcinoma, enhancing its ADC pipeline and global drug development efforts.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.